These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 25450590

  • 1. Honokiol affects melanoma cell growth by targeting the AMP-activated protein kinase signaling pathway.
    Kaushik G, Kwatra D, Subramaniam D, Jensen RA, Anant S, Mammen JM.
    Am J Surg; 2014 Dec; 208(6):995-1002; discussion 1001-2. PubMed ID: 25450590
    [Abstract] [Full Text] [Related]

  • 2. Honokiol inhibits melanoma stem cells by targeting notch signaling.
    Kaushik G, Venugopal A, Ramamoorthy P, Standing D, Subramaniam D, Umar S, Jensen RA, Anant S, Mammen JM.
    Mol Carcinog; 2015 Dec; 54(12):1710-21. PubMed ID: 25491779
    [Abstract] [Full Text] [Related]

  • 3. Honokiol suppresses proliferation and induces apoptosis via regulation of the miR‑21/PTEN/PI3K/AKT signaling pathway in human osteosarcoma cells.
    Yang J, Zou Y, Jiang D.
    Int J Mol Med; 2018 Apr; 41(4):1845-1854. PubMed ID: 29393336
    [Abstract] [Full Text] [Related]

  • 4. Honokiol induces cytotoxic and cytostatic effects in malignant melanoma cancer cells.
    Kaushik G, Ramalingam S, Subramaniam D, Rangarajan P, Protti P, Rammamoorthy P, Anant S, Mammen JM.
    Am J Surg; 2012 Dec; 204(6):868-73. PubMed ID: 23231930
    [Abstract] [Full Text] [Related]

  • 5. Honokiol induces apoptosis and suppresses migration and invasion of ovarian carcinoma cells via AMPK/mTOR signaling pathway.
    Lee JS, Sul JY, Park JB, Lee MS, Cha EY, Ko YB.
    Int J Mol Med; 2019 May; 43(5):1969-1978. PubMed ID: 30864681
    [Abstract] [Full Text] [Related]

  • 6. Downregulation of STAT3 and activation of MAPK are involved in the induction of apoptosis by HNK in glioblastoma cell line U87.
    Zhang Y, Ren X, Shi M, Jiang Z, Wang H, Su Q, Liu Q, Li G, Jiang G.
    Oncol Rep; 2014 Nov; 32(5):2038-46. PubMed ID: 25175884
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Honokiol activates LKB1-miR-34a axis and antagonizes the oncogenic actions of leptin in breast cancer.
    Avtanski DB, Nagalingam A, Bonner MY, Arbiser JL, Saxena NK, Sharma D.
    Oncotarget; 2015 Oct 06; 6(30):29947-62. PubMed ID: 26359358
    [Abstract] [Full Text] [Related]

  • 10. Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis.
    Nagalingam A, Arbiser JL, Bonner MY, Saxena NK, Sharma D.
    Breast Cancer Res; 2012 Feb 21; 14(1):R35. PubMed ID: 22353783
    [Abstract] [Full Text] [Related]

  • 11. Honokiol Affects Stem Cell Viability by Suppressing Oncogenic YAP1 Function to Inhibit Colon Tumorigenesis.
    Subramaniam D, Ponnurangam S, Ramalingam S, Kwatra D, Dandawate P, Weir SJ, Umar S, Jensen RA, Anant S.
    Cells; 2021 Jun 26; 10(7):. PubMed ID: 34206989
    [Abstract] [Full Text] [Related]

  • 12. Honokiol targets mitochondria to halt cancer progression and metastasis.
    Pan J, Lee Y, Wang Y, You M.
    Mol Nutr Food Res; 2016 Jun 26; 60(6):1383-95. PubMed ID: 27276215
    [Abstract] [Full Text] [Related]

  • 13. Honokiol inhibits LPS-induced maturation and inflammatory response of human monocyte-derived dendritic cells.
    Li CY, Chao LK, Wang SC, Chang HZ, Tsai ML, Fang SH, Liao PC, Ho CL, Chen ST, Cheng WC, Chiang CS, Kuo YH, Hua KF, Hsu IC.
    J Cell Physiol; 2011 Sep 26; 226(9):2338-49. PubMed ID: 21660957
    [Abstract] [Full Text] [Related]

  • 14. Honokiol inhibits signal transducer and activator of transcription-3 signaling, proliferation, and survival of hepatocellular carcinoma cells via the protein tyrosine phosphatase SHP-1.
    Rajendran P, Li F, Shanmugam MK, Vali S, Abbasi T, Kapoor S, Ahn KS, Kumar AP, Sethi G.
    J Cell Physiol; 2012 May 26; 227(5):2184-95. PubMed ID: 21792937
    [Abstract] [Full Text] [Related]

  • 15. Antineoplastic Effects of Honokiol on Melanoma.
    Guillermo-Lagae R, Santha S, Thomas M, Zoelle E, Stevens J, Kaushik RS, Dwivedi C.
    Biomed Res Int; 2017 May 26; 2017():5496398. PubMed ID: 28194418
    [Abstract] [Full Text] [Related]

  • 16. Exploiting Honokiol-induced ER stress CHOP activation inhibits the growth and metastasis of melanoma by suppressing the MITF and β-catenin pathways.
    Chiu CS, Tsai CH, Hsieh MS, Tsai SC, Jan YJ, Lin WY, Lai DW, Wu SM, Hsing HY, Arbiser JL, Sheu ML.
    Cancer Lett; 2019 Feb 01; 442():113-125. PubMed ID: 30391358
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Honokiol activates the LKB1-AMPK signaling pathway and attenuates the lipid accumulation in hepatocytes.
    Seo MS, Kim JH, Kim HJ, Chang KC, Park SW.
    Toxicol Appl Pharmacol; 2015 Apr 15; 284(2):113-24. PubMed ID: 25737164
    [Abstract] [Full Text] [Related]

  • 19. Honokiol abrogates leptin-induced tumor progression by inhibiting Wnt1-MTA1-β-catenin signaling axis in a microRNA-34a dependent manner.
    Avtanski DB, Nagalingam A, Kuppusamy P, Bonner MY, Arbiser JL, Saxena NK, Sharma D.
    Oncotarget; 2015 Jun 30; 6(18):16396-410. PubMed ID: 26036628
    [Abstract] [Full Text] [Related]

  • 20. Down-regulation of c-Src/EGFR-mediated signaling activation is involved in the honokiol-induced cell cycle arrest and apoptosis in MDA-MB-231 human breast cancer cells.
    Park EJ, Min HY, Chung HJ, Hong JY, Kang YJ, Hung TM, Youn UJ, Kim YS, Bae K, Kang SS, Lee SK.
    Cancer Lett; 2009 May 18; 277(2):133-40. PubMed ID: 19135778
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.